News

Sanofi reportedly halts sales of cholesterol drug Praluent in China amid limited availability

Sanofi (SNY) halts shipments of cholesterol drug Praluent developed with Regeneron (REGN) due to availability issues. Read ...

Sanofi stops supply of high cholesterol drug to China due to limited availability

Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

Sanofi halts Praluent supply in China due to limited availability

Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability of the popular cholesterol medication.